Inogen beats expectations and stock soars

You are here: Home > Biotech > Current Article

By Staff Report / Tuesday, November 5th, 2019 / Comments Off on Inogen beats expectations and stock soars

Revenue and net income declined for Goleta-based Inogen in the third quarter, but the results outpaced analyst expectations, sending the stock up 9.5 percent in after-hours trading to $65. The oxygen concentrator developer reported $91.8 million in revenue, edging past average analyst estimates, while earnings per share of 31 cents blew past forecasts of 23…

This article is only available to Business Times subscribers

Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
Check the STATUS of your Subscription Account.